Canaan Partners XI LLC
Related Filers (5)
- Canaan XI L.P. (9)
- Day One Biopharmaceuticals, Inc. (7)
- Tyra Biosciences, Inc. (2)
- Canaan Partners 2020+ Co-Investment LLC (2)
- Canaan 2020+ Co-Investment L.P. Series 7 (2)
- Show More ...
Other (9)
13F-HR
Thursday, 2/1/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 10/11/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 7/13/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 4/6/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 2/1/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 10/31/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 8/10/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 4/28/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 2/3/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Ownership (9)
4
Thursday, 9/22/2022
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/20/2022
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/15/2022
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/22/2021
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/9/2021
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/20/2021
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/14/2021
Tyra Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/2/2021
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/26/2021
Day One Biopharmaceuticals, Inc.: Initial statement of beneficial ownership of securities